We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evgen Pharma Plc | LSE:EVG | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -0.51 | 2.06M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/1/2023 21:50 | I cannot seem to open the chart you posted last week, David. Can you tell me what the potential trend line is, based on recent movements? | lovewinshatelosses | |
16/1/2023 20:40 | David Gruen, as you clearly are a chart expert, would you expect a lot of traders that rely on charts to trade, are now likely to start buying, on the basis of what you say is confirmation of the strong up trend, that you kindly provided a impressive chart and explanation of on Friday, which is now clearly bearing the fruits of your knowledge. I look forward to the charts predictions being fulfilled, and your comments on the likely hood of other chart traders having identified what you have, and investing because momentum gains. | clocktower | |
16/1/2023 20:34 | Yes massive, hence why I'm buying 100ks of shares sub 8p placing price. When this moves it moves | wololol | |
16/1/2023 20:30 | Ah. Thanks. (& that is a big area surely, & surely/phps with public/EU/USA money available to help fund trials/development phps) | smithie6 | |
16/1/2023 20:26 | For the breast cancer trials they are in partner discussion that's the main focus area. They have stated it in their interviews over the last few months. | wololol | |
16/1/2023 20:25 | SFX-01 "Evgen-sponsored human volunteer Phase 1 study (anticipated during Q2 2023)." How much does that cost EVG ? What is the prior success data before this phase 1 study ? (I have read too many RNSs from different companies recently, that I can't recall the pre phase 1 status/success for SFX-01) | smithie6 | |
16/1/2023 20:17 | Wololol. Post 1174 "They are in late discussions with partners hence why they can't buy shares in the market." Can you remind me/us who you think they might be in talks with or for what product/IP ? SFX-01, for use in a different application than agreed with in the Oct '22 RNS. ( With Sticalia or something) | smithie6 | |
16/1/2023 16:19 | The volume traded is miniscule still (under 0.5%) lots of shares in tightly held positions make this move fast when it goes. When it starts to rise its always very difficult to buy in volume. I'm not buying anymore but not selling anytime soon either | markth126 | |
16/1/2023 16:14 | If it breaks 5p today I think will see fireworks tomorrow. A few more decent size buys should do it. | wololol | |
16/1/2023 16:07 | Still vastly under the radar. Think when the inevitable herd arrives if it breaks 8p things could get very very interesting | wololol | |
16/1/2023 15:56 | Agreed. Chart wise there's no better time to buy. Even better than the recent lows, as we now have confirmation. | david gruen | |
16/1/2023 15:54 | Just bought another 21k. Irresistible at this price | wololol | |
16/1/2023 15:36 | Whatever happened to MoneyMunch? | david gruen | |
16/1/2023 15:33 | We should break past 5p. Hope all are well. | manual dexterity | |
16/1/2023 15:30 | News can land anytime with this one. They are in late discussions with partners hence why they can't buy shares in the market. | wololol | |
16/1/2023 15:26 | We've moving into the third wave up. Do we expect any news to act as the catalyst any time soon? | david gruen | |
16/1/2023 15:18 | Last placing price was at 8p and since then there have been transformative developments. Plenty of upside from here. Should be valued at least 8p. | wololol | |
16/1/2023 15:10 | HEMO now £40m market cap (advfn have it wrong) and rapidly running out of cash. Long way from starting clinical trials on humans as well, they will be testing on monkeys first which they don't have the cash to do. Whereas EVG a mere £12m cap with £7m+ cash in the bank and proper licencing deals in the bag, with multiple clinical trials underway or starting in the next year. So not too surprising if profits from there are finding their way here. | on target | |
16/1/2023 15:10 | I doubt I will never understand why people only want to buy stocks when they are moving quickly. I thought they were going to shake EVG earlier down to 4.2p now we could break 5p again but one sale they all sell type of market atm | dave4545 | |
16/1/2023 15:07 | HEMO investors are switching I guess. | clocktower | |
16/1/2023 14:56 | More deals in the pipeline? | david gruen | |
16/1/2023 14:52 | It's funny every time that plonker turns up the stock rises - it did on IQAI last week shortly after he showed up - must be my lucky charm dave4545. | clocktower | |
16/1/2023 14:41 | Nothing like a 356k buy to wake your stock up, they were not bothered about splitting and saving 0.15p either | dave4545 | |
16/1/2023 14:30 | You are a complete muppet how do you know i still own FCS,what a clown. You're a pathetic low class awful smelling trolldog to put it politely. If you post your garbage on my threads i can do same on yours. I know it really upsets you muppet. | z1co |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions